-
1
-
-
0030577120
-
Papillomavirus Infections - A major cause of human cancers
-
zur Hausen H: Papillomavirus Infections - a major cause of human cancers. Biochem Biophys Acta (1996) 1288:F55-78.
-
(1996)
Biochem Biophys Acta
, vol.1288
-
-
Zur Hausen, H.1
-
2
-
-
0027050013
-
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly Immunogenic
-
Kimbauer R, Booy F, Cheng N, Lowy DR, Schiller JT: Papillomavirus L1 major capsid protein self-assembles Into virus-like particles that are highly Immunogenic. Proc Natl Acad Sci USA (1992) 89:12180-12184.
-
(1992)
Proc Natl Acad Sci USA
, vol.89
, pp. 12180-12184
-
-
Kimbauer, R.1
Booy, F.2
Cheng, N.3
Lowy, D.R.4
Schiller, J.T.5
-
3
-
-
0028120905
-
Interaction of human Papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an Intact L2 N-terminal sequence
-
Zhou J, Sun XY, Louis K, Frazer IH: Interaction of human Papillomavirus (HPV) type 16 capsid proteins with HPV DNA requires an Intact L2 N-terminal sequence. J Virol (1994) 68:619-625.
-
(1994)
J Virol
, vol.68
, pp. 619-625
-
-
Zhou, J.1
Sun, X.Y.2
Louis, K.3
Frazer, I.H.4
-
4
-
-
0029041842
-
Prevalence of human papillomavirus in cervical cancer: A worldwid perspective
-
Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, Schiffman MH, Moreno V, Kurman R, Shah KV: Prevalence of human papillomavirus In cervical cancer: A worldwid perspective. J Natl Cancer Inst (1995) 87:796-802.
-
(1995)
J Natl Cancer Inst
, vol.87
, pp. 796-802
-
-
Bosch, F.X.1
Manos, M.M.2
Munoz, N.3
Sherman, M.4
Jansen, A.M.5
Peto, J.6
Schiffman, M.H.7
Moreno, V.8
Kurman, R.9
Shah, K.V.10
-
5
-
-
0027428414
-
Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus like particles
-
Kimbauer R, Taub J, Greenstone H, Roden R, Durst M, Gissmann L, Lowy DR, Schiller JT: Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 Into virus like particles. J Virol (1993) 67:6929-6936.
-
(1993)
J Virol
, vol.67
, pp. 6929-6936
-
-
Kimbauer, R.1
Taub, J.2
Greenstone, H.3
Roden, R.4
Durst, M.5
Gissmann, L.6
Lowy, D.R.7
Schiller, J.T.8
-
6
-
-
0028300962
-
Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids
-
Hagensee ME, Olson NH, Baker TS, Galloway DA: Three-dimensional structure of vaccinia virus-produced human papillomavirus type 1 capsids. J Virol (1994) 68:4503-4505.
-
(1994)
J Virol
, vol.68
, pp. 4503-4505
-
-
Hagensee, M.E.1
Olson, N.H.2
Baker, T.S.3
Galloway, D.A.4
-
8
-
-
0027397943
-
Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins
-
Hagensee ME, Yaegashi N, Galloway DA: Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins. J Virol (1993) 67:315-322.
-
(1993)
J Virol
, vol.67
, pp. 315-322
-
-
Hagensee, M.E.1
Yaegashi, N.2
Galloway, D.A.3
-
9
-
-
0027930718
-
Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies
-
Christensen ND, Hopfi R, DiAngelo SL, Cladel NM, Patrick SD, Welsh, PA, Budgeon LR, Reed CA, Kreider JW: Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies. J Gen Virol (1994) 75:2271-2276.
-
(1994)
J Gen Virol
, vol.75
, pp. 2271-2276
-
-
Christensen, N.D.1
Hopfi, R.2
DiAngelo, S.L.3
Cladel, N.M.4
Patrick, S.D.5
Welsh, P.A.6
Budgeon, L.R.7
Reed, C.A.8
Kreider, J.W.9
-
10
-
-
0025331023
-
Antibody-mediated neutralization in vivo of Infectious papillomaviruses
-
Christensen ND, Kreider JW: Antibody-mediated neutralization In vivo of Infectious papillomaviruses. J Virol (1990) 64:3151-3156.
-
(1990)
J Virol
, vol.64
, pp. 3151-3156
-
-
Christensen, N.D.1
Kreider, J.W.2
-
11
-
-
0029841214
-
In vitro generation and type-specific neutralization of a human papillomavirus type 16 virlon pseudotype
-
Roden RB, Greenstone HL, Kimbauer R, Booy FP, Jessie J, Lowy DR, Schiller JT: In vitro generation and type-specific neutralization of a human papillomavirus type 16 virlon pseudotype. J Virol (1996) 70:5875-5883. This paper demonstrates that neutralization of an HPV-16 pseudovirion is dependent on type-specific antibodies.
-
(1996)
J Virol
, vol.70
, pp. 5875-5883
-
-
Roden, R.B.1
Greenstone, H.L.2
Kimbauer, R.3
Booy, F.P.4
Jessie, J.5
Lowy, D.R.6
Schiller, J.T.7
-
12
-
-
0031905637
-
In vitro Infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16
-
White WI, Wilson SD, Bonnez W, Rose RC, Koenig S, Suzich JA: In vitro Infection and type-restricted antibody-mediated neutralization of authentic human papillomavirus type 16. J Virol (1998) 72:959-964. This paper demonstrates that authentic HPV virions can be neutralized with antibodies induced by HPV-16 VLPs and neutralization is type-restricted.
-
(1998)
J Virol
, vol.72
, pp. 959-964
-
-
White, W.I.1
Wilson, S.D.2
Bonnez, W.3
Rose, R.C.4
Koenig, S.5
Suzich, J.A.6
-
13
-
-
0028113962
-
Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins
-
Roden RB, Weissinger EM, Henderson DW, Booy F, Kimbauer R, Mushinski, JF, Lowy DR, Schiller JT: Neutralization of bovine papillomavirus by antibodies to L1 and L2 capsid proteins. J Virol (1994) 68:7570-7574.
-
(1994)
J Virol
, vol.68
, pp. 7570-7574
-
-
Roden, R.B.1
Weissinger, E.M.2
Henderson, D.W.3
Booy, F.4
Kimbauer, R.5
Mushinski, J.F.6
Lowy, D.R.7
Schiller, J.T.8
-
14
-
-
0032486389
-
A surface Immunodeterminant of human papillomavirus type 16 minor capsid protein L2
-
Kawana K, Matsumoto K, Yoshikawa H, Taketani Y, Kawana T, Yoshiike K, Kanda T: A surface Immunodeterminant of human papillomavirus type 16 minor capsid protein L2. Virology (1998) 248:353-359.
-
(1998)
Virology
, vol.248
, pp. 353-359
-
-
Kawana, K.1
Matsumoto, K.2
Yoshikawa, H.3
Taketani, Y.4
Kawana, T.5
Yoshiike, K.6
Kanda, T.7
-
15
-
-
0029025444
-
Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV Infection
-
Breitburd F, Kimbauer R, Hubbert NL, Nonnenmacher B, Trin-Dinh-Desmarquet C, Orth G, Schiller JT, Lowy DR: Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV Infection. J Virol (1995) 69:3959-3963. Immunization with CRPV VLPs protects against papillomas and carcinoma induced by CRPV, and protection is mediated by antibodies to L1 conformational epitopes.
-
(1995)
J Virol
, vol.69
, pp. 3959-3963
-
-
Breitburd, F.1
Kimbauer, R.2
Hubbert, N.L.3
Nonnenmacher, B.4
Trin-Dinh-Desmarquet, C.5
Orth, G.6
Schiller, J.T.7
Lowy, D.R.8
-
16
-
-
0028845930
-
Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-lnduced papilloma formation
-
Jansen KU, Rosolowsky M, Schultz LD, Markus HZ, Cook JC, Donnelly JJ, MarBnez D, Ellis RW, Shaw AR: Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-lnduced papilloma formation. Vaccine (1995) 13:1509-1514. Immunization with CRPV VLPs protects against papillomas induced by CRPV.
-
(1995)
Vaccine
, vol.13
, pp. 1509-1514
-
-
Jansen, K.U.1
Rosolowsky, M.2
Schultz, L.D.3
Markus, H.Z.4
Cook, J.C.5
Donnelly, J.J.6
MarBnez, D.7
Ellis, R.W.8
Shaw, A.R.9
-
17
-
-
0030048139
-
Immunization with virus-like particles Induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus
-
Christensen ND, Reed CA, Qadel NM, Han R, Kreider JW: Immunization with virus-like particles Induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus. J Virol (1996) 70:960-965. Strong and long-lasting protection against challenge with CRPV is achieved with immunization with CRPV VLPs.
-
(1996)
J Virol
, vol.70
, pp. 960-965
-
-
Christensen, N.D.1
Reed, C.A.2
Qadel, N.M.3
Han, R.4
Kreider, J.W.5
-
18
-
-
0029610072
-
Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas
-
Suzich JA, Ghim SJ, Palmer-Hill FJ, White WI, Tamura JK, Bell JA, Newsome JA, Jenson AB, Schiegel R: Systemic immunization with papillomavirus L1 protein completely prevents the development of viral mucosal papillomas. Proc Natl Acad Sci USA (1995) 92:11553-11557.
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, pp. 11553-11557
-
-
Suzich, J.A.1
Ghim, S.J.2
Palmer-Hill, F.J.3
White, W.I.4
Tamura, J.K.5
Bell, J.A.6
Newsome, J.A.7
Jenson, A.B.8
Schiegel, R.9
-
19
-
-
0030001427
-
Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic Immunization
-
Kimbauer R, Chandrachud LM, O'Neil BW, Wagner ER, Grindlay GJ, Armstrong A, McGarvie GM, Schiller JT, Lowy DR, Campo MS: Virus-like particles of bovine papillomavirus type 4 In prophylactic and therapeutic Immunization. Virology (1996) 219:37-44. Animal model demonstrating the effectiveness of VLPs as Immunogens for prophylactic vaccination.
-
(1996)
Virology
, vol.219
, pp. 37-44
-
-
Kimbauer, R.1
Chandrachud, L.M.2
O'Neil, B.W.3
Wagner, E.R.4
Grindlay, G.J.5
Armstrong, A.6
McGarvie, G.M.7
Schiller, J.T.8
Lowy, D.R.9
Campo, M.S.10
-
20
-
-
0031950209
-
Isolation and propagation of human papillomavirus type 16 in human xenografts implanted in the severe combined Immunodeficiency mouse
-
Bonnez W, DaRin C, Borkhuis C, de Mesy Jensen K, Relehman RC, Rose RC. Isolation and propagation of human papillomavirus type 16 In human xenografts implanted In the severe combined Immunodeficiency mouse. J Virol (1998) 72:5256-5261. HPV16 virions are propagated from human foreskin fragments impianted in SCID mice. Passage of the virus caused SIL-like lesions.
-
(1998)
J Virol
, vol.72
, pp. 5256-5261
-
-
Bonnez, W.1
DaRin, C.2
Borkhuis, C.3
De Mesy Jensen, K.4
Relehman, R.C.5
Rose, R.C.6
-
21
-
-
0028888363
-
Immunization of mice with HPV vaccinia virus recombinants generates serum IgG, IgM, and mucosal IgA antibodies
-
Hagensee ME, Carter JJ, Wipf GC, Galloway DA: Immunization of mice with HPV vaccinia virus recombinants generates serum IgG, IgM, and mucosal IgA antibodies. Virology (1995) 206:174-182.
-
(1995)
Virology
, vol.206
, pp. 174-182
-
-
Hagensee, M.E.1
Carter, J.J.2
Wipf, G.C.3
Galloway, D.A.4
-
22
-
-
16944364476
-
Human papillomavirus type 11 (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys Immunized with HPV-11 virus-like particles expressed in yeast
-
Lowe RS, Brown DR, Bryan JT, Cook JC, George HA, Hofmann KJ, Humi, WM, Joyce JG, Lehman ED, Markus HZ, Neeper MP, Schultz LD, Shaw AR, Jansen KU: Human papillomavirus type 11 (HPV-11) neutralizing antibodies In the serum and genital mucosal secretions of African green monkeys Immunized with HPV-11 virus-like particles expressed In yeast J Infect Dis. (1997) 176:1141-1145.
-
(1997)
J Infect Dis.
, vol.176
, pp. 1141-1145
-
-
Lowe, R.S.1
Brown, D.R.2
Bryan, J.T.3
Cook, J.C.4
George, H.A.5
Hofmann, K.J.6
Humi, W.M.7
Joyce, J.G.8
Lehman, E.D.9
Markus, H.Z.10
Neeper, M.P.11
Schultz, L.D.12
Shaw, A.R.13
Jansen, K.U.14
-
23
-
-
0031668082
-
Nasal Immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies in mucosal secretions
-
Balmeili C, Roden R, Potts A, Schiller J, De Grandi P, Nardelli-Haefliger D: Nasal Immunization of mice with human papillomavirus type 16 virus-like particles elicits neutralizing antibodies In mucosal secretions. J Virol (1998) 72:8220-8229. Long-lasting titers of IgA and IgG anti-HPV16 VLP antibodies are found in saliva and genital secretions after nasal immunization of mice.
-
(1998)
J Virol
, vol.72
, pp. 8220-8229
-
-
Balmeili, C.1
Roden, R.2
Potts, A.3
Schiller, J.4
De Grandi, P.5
Nardelli-Haefliger, D.6
-
24
-
-
0029845430
-
Virus-like particles Induce MHC class 1-restricted T-cell responses. Lessons learned from the hepatitis B small surface antigen
-
Schirmbeck R, Bohm W, Reimann J: Virus-like particles Induce MHC class 1-restricted T-cell responses. Lessons learned from the hepatitis B small surface antigen. Intervirology (1996) 39:111-119.
-
(1996)
Intervirology
, vol.39
, pp. 111-119
-
-
Schirmbeck, R.1
Bohm, W.2
Reimann, J.3
-
25
-
-
0029801019
-
Genetically engineered particulate virus-like structures and their use as vaccine delivery systems
-
Roy P: Genetically engineered particulate virus-like structures and their use as vaccine delivery systems. Intervirology (1996) 39:62-71.
-
(1996)
Intervirology
, vol.39
, pp. 62-71
-
-
Roy, P.1
-
26
-
-
10544230643
-
Synthesis and assembly of chlmeric human Immunodeficiency virus gag pseudovirions
-
Tobin GJ, Li GH, Williamson JC, Nagashima K, Gonda MA: Synthesis and assembly of chlmeric human Immunodeficiency virus gag pseudovirions. Intervirology (1996) 39:40-48.
-
(1996)
Intervirology
, vol.39
, pp. 40-48
-
-
Tobin, G.J.1
Li, G.H.2
Williamson, J.C.3
Nagashima, K.4
Gonda, M.A.5
-
27
-
-
0030273342
-
MHC class I-restricted CTL responses to exogenous antigens
-
Jondal M, Schirmbeck R, Reimann J: MHC class I-restricted CTL responses to exogenous antigens. Immunity (1996) 5:295-302.
-
(1996)
Immunity
, vol.5
, pp. 295-302
-
-
Jondal, M.1
Schirmbeck, R.2
Reimann, J.3
-
28
-
-
0030795494
-
Recombinant parvovirus-llke particles as an antigen carrier: A novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxlc T-cells
-
Sedlik C, Saron M, Sarraseca J, Casal I, Leclerc C: Recombinant parvovirus-llke particles as an antigen carrier: A novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxlc T-cells. Proc Natl Acad Sci USA (1997) 94:7503-7508.
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 7503-7508
-
-
Sedlik, C.1
Saron, M.2
Sarraseca, J.3
Casal, I.4
Leclerc, C.5
-
29
-
-
0027283942
-
Induction of HIV-speciflc cytotoxlc T-lymphocytes in vivo with hybrid HIV-1 V3:Ty-virus-like particles
-
Layton GT, Harris SJ, Gearing AJ, Hill-Perkins M, Cole JS, Griffiths, JC, Bums NR, Kingsman AJ, Adams SE: Induction of HIV-speciflc cytotoxlc T-lymphocytes in vivo with hybrid HIV-1 V3:Ty-virus-like particles. J Immunol (1993) 151:1097-1107.
-
(1993)
J Immunol
, vol.151
, pp. 1097-1107
-
-
Layton, G.T.1
Harris, S.J.2
Gearing, A.J.3
Hill-Perkins, M.4
Cole, J.S.5
Griffiths, J.C.6
Bums, N.R.7
Kingsman, A.J.8
Adams, S.E.9
-
30
-
-
0030713343
-
A protein particle vaccine containing multiple malaria epltopes
-
Gilbert SC, Plebanski M, Harris SJ, Allsopp CE, Thomas R, Layton GT, Hill AV: A protein particle vaccine containing multiple malaria epltopes. Nature Biotechnol (1997) 15:1280-1284.
-
(1997)
Nature Biotechnol
, vol.15
, pp. 1280-1284
-
-
Gilbert, S.C.1
Plebanski, M.2
Harris, S.J.3
Allsopp, C.E.4
Thomas, R.5
Layton, G.T.6
Hill, A.V.7
-
31
-
-
0028316949
-
Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: Consequences for the phenotype and E6-p53 and E7-pRB Interactions
-
Von Knebel Doeberitz M, Rittmuller C, Aengeneyndt F, Jansen-Durr P, Spitkovsky D: Reversible repression of papillomavirus oncogene expression In cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB Interactions. J Virol (1994) 68:2811-2821.
-
(1994)
J Virol
, vol.68
, pp. 2811-2821
-
-
Von Knebel Doeberitz, M.1
Rittmuller, C.2
Aengeneyndt, F.3
Jansen-Durr, P.4
Spitkovsky, D.5
-
32
-
-
0031582649
-
Chlmeric papillomavirus-like particles
-
Müller M, Zhou J, Reed TO, Rittmuller C, Burger A, Gabelsberger J, Braspenning J, Gissmann L: Chlmeric papillomavirus-like particles. Virology (1997) 234:93-111.
-
(1997)
Virology
, vol.234
, pp. 93-111
-
-
Müller, M.1
Zhou, J.2
Reed, T.O.3
Rittmuller, C.4
Burger, A.5
Gabelsberger, J.6
Braspenning, J.7
Gissmann, L.8
-
33
-
-
0032484471
-
Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway
-
Peng S, Frazer IH, Fernando GJ, Zhou J: Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway. Virology (1998) 240:147-157.
-
(1998)
Virology
, vol.240
, pp. 147-157
-
-
Peng, S.1
Frazer, I.H.2
Fernando, G.J.3
Zhou, J.4
-
34
-
-
0032539564
-
Chlmeric papillomavirus virus-like particles elicit antltumor Immunity against the E7 oncoprotein in an HPV16 tumor model
-
Greenstone HL, Nieland JD, de Visser KE, De Bruijn ML, Kimbauer R, Roden RBS, Lowy DR, Kast WM, Schiller JT: Chlmeric papillomavirus virus-like particles elicit antltumor Immunity against the E7 oncoprotein In an HPV16 tumor model. Proc Natl Acad Sci USA (1998) 95:1800-1805.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 1800-1805
-
-
Greenstone, H.L.1
Nieland, J.D.2
De Visser, K.E.3
De Bruijn, M.L.4
Kimbauer, R.5
Roden, R.B.S.6
Lowy, D.R.7
Kast, W.M.8
Schiller, J.T.9
-
35
-
-
0028152971
-
Interaction of papillomaviruses with the cell surface
-
Roden RB, Kimbauer R, Jenson AB, Lowy DR, Schiller JT: Interaction of papillomaviruses with the cell surface. J Virol (1994) 68:7260-7266.
-
(1994)
J Virol
, vol.68
, pp. 7260-7266
-
-
Roden, R.B.1
Kimbauer, R.2
Jenson, A.B.3
Lowy, D.R.4
Schiller, J.T.5
-
36
-
-
0028829923
-
Papillomavirus capald binding and uptake by cells from different tissues and species
-
Müller M, Gissmann L, Cristiano RJ, Sun XY, Frazer IH, Jenson AB, Alonso A, Zentgraf H, Zhou J: Papillomavirus capald binding and uptake by cells from different tissues and species. J Virol (1995) 69:948-954.
-
(1995)
J Virol
, vol.69
, pp. 948-954
-
-
Müller, M.1
Gissmann, L.2
Cristiano, R.J.3
Sun, X.Y.4
Frazer, I.H.5
Jenson, A.B.6
Alonso, A.7
Zentgraf, H.8
Zhou, J.9
-
37
-
-
0028811410
-
Early phase in the Infection of cultured cells with papillomavirus virions
-
Zhou J, Gissmann L, Zentgraf H, Müller H, Picken M, Müller M: Early phase In the Infection of cultured cells with papillomavirus virions. Virology (1995) 214:167-176. Electron microscopic and immunofluorescence data showing that capsid proteins of bovine papillomavirus virions and BPV VLPs are found In the nucleus of Infected cells, then degraded and deposited In the Golgi apparatus.
-
(1995)
Virology
, vol.214
, pp. 167-176
-
-
Zhou, J.1
Gissmann, L.2
Zentgraf, H.3
Müller, H.4
Picken, M.5
Müller, M.6
-
38
-
-
0028850506
-
Processing of exogenous heat-aggregated (denatured) and partlculate (native) hepatitis B surface antigen for class -restricted epltope presentation
-
Schlrmbeck R, Bohm W, Melber K, Relmann J: Processing of exogenous heat-aggregated (denatured) and partlculate (native) hepatitis B surface antigen for class (-restricted epltope presentation. J Immunol (1995) 155:4676-4684.
-
(1995)
J Immunol
, vol.155
, pp. 4676-4684
-
-
Schlrmbeck, R.1
Bohm, W.2
Melber, K.3
Relmann, J.4
-
39
-
-
0029856741
-
Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T-lymphocytes
-
Bachmann MF, Lutz MB, Layton GT, Harris SJ, Fehr T, Rescigno M, Ricciardi-Castagnoli P: Dendritic cells process exogenous viral proteins and virus-like particles for class I presentation to CD8+ cytotoxic T-lymphocytes. Eur J Immunol (MSB) 26:2595-2600.
-
Eur J Immunol (MSB)
, vol.26
, pp. 2595-2600
-
-
Bachmann, M.F.1
Lutz, M.B.2
Layton, G.T.3
Harris, S.J.4
Fehr, T.5
Rescigno, M.6
Ricciardi-Castagnoli, P.7
-
40
-
-
0031127553
-
Cell mediated Immunity Induced in mice by HPV 16 L1 virus-like particles
-
Dupuy C, Buzoni-Gatel D, Touze A, Le Cann P, Bout D, Coursaget P: Cell mediated Immunity Induced In mice by HPV 16 L1 virus-like particles. Microbial Pathogenesis (1997) 22:219-225. Data are presented which demonstrate that VLPs Induce cellular Immunity In addition to previously described humoral Immunity.
-
(1997)
Microbial Pathogenesis
, vol.22
, pp. 219-225
-
-
Dupuy, C.1
Buzoni-Gatel, D.2
Touze, A.3
Le Cann, P.4
Bout, D.5
Coursaget, P.6
-
41
-
-
0026514428
-
Human papillomavirus type 16 and 18 gene expression in cervical neoplaslas
-
Stoler MH, Rhodes CR, Whitbeck A, Wolinsky SM, Chow LT, Broker TR: Human papillomavirus type 16 and 18 gene expression In cervical neoplaslas. Hum Pathol (1992) 23:117-128.
-
(1992)
Hum Pathol
, vol.23
, pp. 117-128
-
-
Stoler, M.H.1
Rhodes, C.R.2
Whitbeck, A.3
Wolinsky, S.M.4
Chow, L.T.5
Broker, T.R.6
-
42
-
-
0032566921
-
L1-specific protection from tumor challenge elicited by HPV16 virus-like particles
-
De Bruijn ML, Greenstone HL, Vermeulen H, Melief CJM, Lowy DR, Schiller JT, Kast WM: L1-specific protection from tumor challenge elicited by HPV16 virus-like particles. Virology (1998) 250:371-376. This paper demonstrates that L1 protein of HPV16 expressed In an HPV16 genome-transformed cell line can function as a tumor rejection antigen. Immunization is performed with HPV16 L1 VLPs.
-
(1998)
Virology
, vol.250
, pp. 371-376
-
-
De Bruijn, M.L.1
Greenstone, H.L.2
Vermeulen, H.3
Melief, C.J.M.4
Lowy, D.R.5
Schiller, J.T.6
Kast, W.M.7
-
43
-
-
0027320440
-
Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor Induced by human papillomavirus type 16-transformed cells
-
Feltkamp MC, Smits HL, Vierboom MP, Minnaar RP, de Jongh BM, Drijfhout JW, ter Schegget J, Mellef CJM, Kast WM: Vaccination with cytotoxic T lymphocyte epitope-containing peptide protects against a tumor Induced by human papillomavirus type 16-transformed cells. Eur J Immunol (1993) 23:2242-2249.
-
(1993)
Eur J Immunol
, vol.23
, pp. 2242-2249
-
-
Feltkamp, M.C.1
Smits, H.L.2
Vierboom, M.P.3
Minnaar, R.P.4
De Jongh, B.M.5
Drijfhout, J.W.6
Ter Schegget, J.7
Mellef, C.J.M.8
Kast, W.M.9
-
44
-
-
0029143546
-
Cytotoxic T-lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-lnduced tumors
-
Feltkamp MC, Vreugdenhil GR, Vierboom MP, Ras E, van der Burg SH, ter Schegget J, Melief CJM, Kast WM: Cytotoxic T-lymphocytes raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-lnduced tumors. Eur J Immunol (1995) 25:2638-2642.
-
(1995)
Eur J Immunol
, vol.25
, pp. 2638-2642
-
-
Feltkamp, M.C.1
Vreugdenhil, G.R.2
Vierboom, M.P.3
Ras, E.4
Van Der Burg, S.H.5
Ter Schegget, J.6
Melief, C.J.M.7
Kast, W.M.8
-
45
-
-
0028793675
-
Bone marrow-derived dendritic cells pulsed with synthetic tumour peptldes elicit protective and therapeutic antitumour Immunity
-
Mayordomo JI, Zorina T, Storkus WJ, Zitvogel L, Celluzzi C, Falo LD, Melief CJM, Ildstad ST, Kast WM, Deleo AB, Lotze MT: Bone marrow-derived dendritic cells pulsed with synthetic tumour peptldes elicit protective and therapeutic antitumour Immunity. Nature Med (1995) 1:1297-1302.
-
(1995)
Nature Med
, vol.1
, pp. 1297-1302
-
-
Mayordomo, J.I.1
Zorina, T.2
Storkus, W.J.3
Zitvogel, L.4
Celluzzi, C.5
Falo, L.D.6
Melief, C.J.M.7
Ildstad, S.T.8
Kast, W.M.9
Deleo, A.B.10
Lotze, M.T.11
-
46
-
-
0028231616
-
Immune response to human papillomaviruses and the prospects for human papillomavirus-specific immunisation
-
Tindle RW, Frazer IH: Immune response to human papillomaviruses and the prospects for human papillomavirus-specific immunisation. Curr Topics Microbiol Immunol (1994) 186:217-253.
-
(1994)
Curr Topics Microbiol Immunol
, vol.186
, pp. 217-253
-
-
Tindle, R.W.1
Frazer, I.H.2
-
47
-
-
2442751256
-
Crucial role of vaccine delivery system and Immune suppressed state in cervical cancer patients undergoing treatment with therapeutic vaccines
-
Stem PL, Carroll M, Beverly PCL (Eds), Cambridge University Press, Cambridge, in press
-
Rudolf MP, Small LA, Velders MP, Da Silva DM, Weljzen S, Kast WM: Crucial role of vaccine delivery system and Immune suppressed state In cervical cancer patients undergoing treatment with therapeutic vaccines. In: Cancer Vaccinas: Strategies, Prospects and Realities of Immune Intervention. Stem PL, Carroll M, Beverly PCL (Eds), Cambridge University Press, Cambridge, in press.
-
Cancer Vaccinas: Strategies, Prospects and Realities of Immune Intervention
-
-
Rudolf, M.P.1
Small, L.A.2
Velders, M.P.3
Da Silva, D.M.4
Weljzen, S.5
Kast, W.M.6
-
48
-
-
0029935569
-
Enhanced tumor outgrowth after peptide vaccination. Functional deletion of tumor-specific CTL Induced by peptide vaccination can lead to the inability to reject tumors
-
Toes REM, Blom RJJ, Offringa R, Kast WM, Melief CJM: Enhanced tumor outgrowth after peptide vaccination. Functional deletion of tumor-specific CTL Induced by peptide vaccination can lead to the inability to reject tumors. J Immunol (1996) 156:3911-3918.
-
(1996)
J Immunol
, vol.156
, pp. 3911-3918
-
-
Toes, R.E.M.1
Blom, R.J.J.2
Offringa, R.3
Kast, W.M.4
Melief, C.J.M.5
-
49
-
-
0029798058
-
Peptide vaccination can lead to enhance tumor growth through specific T-cell tolerance Induction
-
Toes REM, Offringa R, Blom RJJ, Melief CJM, Kast WM: Peptide vaccination can lead to enhance tumor growth through specific T-cell tolerance Induction. Proc Natl Acad Sci USA (1996) 93:7855-7860.
-
(1996)
Proc Natl Acad Sci USA
, vol.93
, pp. 7855-7860
-
-
Toes, R.E.M.1
Offringa, R.2
Blom, R.J.J.3
Melief, C.J.M.4
Kast, W.M.5
-
50
-
-
0032080385
-
Enhancement of tumor outgrowth through CTL tolerlzation after peptide vaccination Is avoided by peptide presentation on dendritic cells
-
Toes REM, Vandervoort EIH, Schoenberger SP, Drijfhout JW, Vanbloois L, Storm G, Kast WM, Offringa R, Melief CJM: Enhancement of tumor outgrowth through CTL tolerlzation after peptide vaccination Is avoided by peptide presentation on dendritic cells. J Immunol (1998) 160:4449-4456.
-
(1998)
J Immunol
, vol.160
, pp. 4449-4456
-
-
Toes, R.E.M.1
Vandervoort, E.I.H.2
Schoenberger, S.P.3
Drijfhout, J.W.4
Vanbloois, L.5
Storm, G.6
Kast, W.M.7
Offringa, R.8
Melief, C.J.M.9
-
51
-
-
0030068375
-
Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen
-
Un KY, Guarnleri FG, Staveley-O'Carroll KF, Levitsky HI, August JT, Pardoll DM, Wu TC: Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res (1996) 56:21-26.
-
(1996)
Cancer Res
, vol.56
, pp. 21-26
-
-
Un, K.Y.1
Guarnleri, F.G.2
Staveley-O'Carroll, K.F.3
Levitsky, H.I.4
August, J.T.5
Pardoll, D.M.6
Wu, T.C.7
-
52
-
-
0027985363
-
Localization of two cytotoxic T lymphocyte epitopes and three anchoring residues on a single nonameric peptide that binds to H-2Ld and is recognized by cytotoxic T-lymphocytes against mouse tumor P815
-
Van den Eynde B, Mazarguil H, Lethe B, Laval F, Gairin JE: Localization of two cytotoxic T lymphocyte epitopes and three anchoring residues on a single nonameric peptide that binds to H-2Ld and is recognized by cytotoxic T-lymphocytes against mouse tumor P815. Eur J Immunol (1994) 24:2740-2745.
-
(1994)
Eur J Immunol
, vol.24
, pp. 2740-2745
-
-
Van den Eynde, B.1
Mazarguil, H.2
Lethe, B.3
Laval, F.4
Gairin, J.E.5
-
53
-
-
0031013016
-
In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma
-
Madrigal M, Janicek MF, Sevin BU, Perras J, Estape R, Penalver M, Averette HE: In vitro antigene therapy targeting HPV-16 E6 and E7 In cervical carcinoma. Gynecol Oncol (1997) 64:18-25.
-
(1997)
Gynecol Oncol
, vol.64
, pp. 18-25
-
-
Madrigal, M.1
Janicek, M.F.2
Sevin, B.U.3
Perras, J.4
Estape, R.5
Penalver, M.6
Averette, H.E.7
-
54
-
-
0032030315
-
In vitro gene transfer using human papillomavirus-like particles
-
Touze A, Coursaget P: In vitro gene transfer using human papillomavirus-like particles. Nucleic Acids Res (1998) 26:1317-1323. Data are presented which demonstrate that VLPs can package unrelated plasmid DNA in vitro and deliver foreign DNA to eukaryotic cells with subsequent gene expression.
-
(1998)
Nucleic Acids Res
, vol.26
, pp. 1317-1323
-
-
Touze, A.1
Coursaget, P.2
-
55
-
-
0031058283
-
Antisense targeting of E6AP elevates p53 in HPV-Infectod cells but not in normal cells
-
Beer-Romero P, Glass S, Rolfe M: Antisense targeting of E6AP elevates p53 In HPV-Infectod cells but not in normal cells. Oncogens (1997) 14:595-602.
-
(1997)
Oncogens
, vol.14
, pp. 595-602
-
-
Beer-Romero, P.1
Glass, S.2
Rolfe, M.3
-
56
-
-
0030298504
-
Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells
-
Hamada K, Sakaue M, Alemany R, Zhang WW, Horio Y, Roth JA, Mitchell MF: Adenovirus-mediated transfer of HPV 16 E6/E7 antisense RNA to human cervical cancer cells. Gynecol Oncol (1996) 63:219-227.
-
(1996)
Gynecol Oncol
, vol.63
, pp. 219-227
-
-
Hamada, K.1
Sakaue, M.2
Alemany, R.3
Zhang, W.W.4
Horio, Y.5
Roth, J.A.6
Mitchell, M.F.7
-
57
-
-
0031569119
-
Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentation
-
Cayeux S, Richter G, Noffz G, Dorken B, Blankenstein T: Influence of gene-modified (IL-7, IL-4, and B7) tumor cell vaccines on tumor antigen presentation. J Immunol (1997) 158:2834-2841.
-
(1997)
J Immunol
, vol.158
, pp. 2834-2841
-
-
Cayeux, S.1
Richter, G.2
Noffz, G.3
Dorken, B.4
Blankenstein, T.5
-
58
-
-
0027538181
-
Vaccination with Irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity
-
Dranoff G, Jaffee E, Lazenby A, Golumbek P, Levitsky H, Brose K, Jackson V, Hamada H, Pardoll D, Mulligan RC: Vaccination with Irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA (1993) 90:3539-3543.
-
(1993)
Proc Natl Acad Sci USA
, vol.90
, pp. 3539-3543
-
-
Dranoff, G.1
Jaffee, E.2
Lazenby, A.3
Golumbek, P.4
Levitsky, H.5
Brose, K.6
Jackson, V.7
Hamada, H.8
Pardoll, D.9
Mulligan, R.C.10
-
59
-
-
0029025421
-
Binding and Internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells
-
Volpers C, Unckell F, Schirmacher P, Streeck RE, Sapp M: Binding and Internalization of human papillomavirus type 33 virus-like particles by eukaryotic cells. J Virol (1995) 69:3258-3264.
-
(1995)
J Virol
, vol.69
, pp. 3258-3264
-
-
Volpers, C.1
Unckell, F.2
Schirmacher, P.3
Streeck, R.E.4
Sapp, M.5
-
60
-
-
0031469159
-
Immunomanipulative strategies for the control of human papillomavirus associated cervical disease
-
Tindle RW: Immunomanipulative strategies for the control of human papillomavirus associated cervical disease. Immunologic Res (1997) 16:387-400.
-
(1997)
Immunologic Res
, vol.16
, pp. 387-400
-
-
Tindle, R.W.1
|